Zachary Hunter, PhD
Instructor
Dana-Farber Cancer Institute/ Harvard University




Waldenström's macroglobulinemia
Whole Genome Sequencing
Lymphoma Predisposition
Bioinformatics
Genetics

Predoctoral Trainee (previously held)
Boston University Chobanian & Avedisian School of Medicine, Graduate Medical Sciences
Pathology & Laboratory Medicine


Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Tsakmaklis N, Hunter ZR, Liu X, Kofides A, Liu S, Guerrera ML, Guijosa A, Sun H, Hatcher JM, Peachey A, Patterson CJ, Meid K, Gustine J, Branagan AR, Sarosiek SR, Castillo JJ, Treon SP. Quantitative MYD88L265P and CXCR4S338X analysis to assess clinical trial performance in Waldenstrom macroglobulinemia. Blood Adv. 2026 Mar 24; 10(6):1954-1958. PMID: 41544209; PMCID: PMC12995488; DOI: 10.1182/bloodadvances.2025018605;
     
  2. Sun H, Sklavenitis Pistofidis R, Liu S, Liu X, Tsakmaklis N, Hatcher JM, Guerrera ML, Kofides A, Ramirez-Gamero AF, Peachey A, Li S, Keskin D, Chea V, Kim N, Lyu H, Lu W, Livak KJ, Meid KE, Guijosa A, Flynn C, Pizzarella D, Patterson CJ, Hao M, Yi S, Yuan W, Branagan AR, Wu CJ, Ghobrial IM, Qiu L, Sarosiek S, Castillo JJ, Hunter ZR, Treon SP. Evolution of tumor subclones and T-cell dynamics underlie variable ibrutinib responses in Waldenström macroglobulinemia. Blood. 2026 Feb 11. PMID: 41671559
     
  3. Ramirez-Gamero A, Tsakmaklis N, Hunter ZR, Guerrera ML, Guijosa A, Sarosiek S, Treon SP, Castillo JJ. Familial clusters and clinical features, complications, and outcomes in 1000 patients with Waldenström macroglobulinemia. Blood Adv. 2026 Jan 27; 10(2):334-342. PMID: 41118612; PMCID: PMC12828760; DOI: 10.1182/bloodadvances.2025017312;
     
  4. Sarosiek S, Castillo JJ, Hunter ZR, Branagan AR, Treon SP. Clinicopathological features and management of IgM multiple myeloma and Waldenstrom macroglobulinemia. Leuk Lymphoma. 2026 Jan 21; 1-8. PMID: 41566909
     
  5. Hatcher JM, Liu S, Kofides A, Canning A, Pizzarella D, Liu X, Tsakmaklis N, Guerrera M, Patterson C, Guijosa A, Gokhale P, Hunter Z, Sarosiek S, Castillo J, Wang J, Buhrlage SJ, Treon SP. Discovery and Characterization of a First-In-Class HCK/BTK PROTAC DFCI-002-06 for the Treatment of MYD88 Mutated B Cell Malignancies. J Med Chem. 2026 Jan 22; 69(2):1119-1134. PMID: 41482966
     
  6. Bagratuni T, Theologi O, Vlachos C, Kollias I, Maclachlan K, Aktypi F, Mavrianou-Koutsoukou N, Liacos C, Taouxi K, Papadimou A, Chrisostomidou K, Sakkou M, Solia I, Theodorakakou F, Favrin G, Gavriatopoulou M, Terpos E, Varettoni M, Hunter ZR, Treon S, Maura F, Dimopoulos MA, Kastritis E. Genomic landscape of IgM-MGUS and patients with stable or progressive asymptomatic Waldenström macroglobulinemia. Blood. 2025 Dec 18; 146(25):3086-3097. PMID: 40997305
     
  7. Liu S, Kofides A, Liu X, Hatcher JM, Sun H, Tsakmaklis N, Guijosa A, Guerrera ML, Pizzarella D, Peachey AL, Patterson CJ, Hunter ZR, Meid K, Castillo JJ, Sarosiek SR, Treon SP. Repurposing pacritinib to target MYD88-mutated Waldenström macroglobulinaemia. Br J Haematol. 2026 Feb; 208(2):727-731. PMID: 41255253; PMCID: PMC12645583; DOI: 10.1111/bjh.70254;
     
  8. Castillo JJ, Guijosa A, Allan JN, Siddiqi T, Advani RH, Flynn CA, Meid K, Budano N, Nguyen J, Ramirez-Gamero A, Tsakmaklis N, Hunter ZR, Patterson CJ, Treon SP, Sarosiek S. Long-term follow-up of venetoclax monotherapy in previously treated patients with Waldenström macroglobulinemia. Blood Adv. 2025 Oct 14; 9(19):4842-4847. PMID: 40674749; PMCID: PMC12495091; DOI: 10.1182/bloodadvances.2025016890;
     
  9. Branagan AR, Mo C, Lei M, Gustine JN, Yee AJ, O'Donnell E, Castillo JJ, Nadeem O, Flynn C, Bernstein Z, Nakamoto-Matsubara R, Meid K, Verma R, Hunter ZR, Guerrera ML, Alter G, Burke J, Harrington C, Agyemang E, Gammon M, Lively K, Packer L, Horick N, Laubach J, Mitsiades CS, Munshi N, Anderson KC, Treon SP, Richardson PG, Raje NS, Sarosiek SR. Prospective study of immunogenicity to SARS-CoV-2 booster vaccines in multiple myeloma and Waldenström macroglobulinemia. Blood Adv. 2025 Sep 23; 9(18):4568-4579.View Related Profiles. PMID: 40472329; PMCID: PMC12452669; DOI: 10.1182/bloodadvances.2025016513;
     
  10. Hunter ZR, Treon SP. Distinct molecular subtypes in Waldenström macroglobulinemia. Blood. 2025 Sep 04; 146(10):1153-1154. PMID: 40906500
     
Showing 10 of 162 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 162 publications over 22 distinct years, with a maximum of 15 publications in 2018 and 2020

YearPublications
20045
20053
20066
20076
200811
20096
201112
20123
20135
201410
20158
201613
20177
201815
20195
202015
20219
20225
20231
20244
20258
20265

Contact for Mentoring:

Hunter's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
See all (397) concept(s)
_
Co-Authors
See all (3) people
_
Similar People
See all (60) people
_